Your.MD - Frontiers Health 2018 Presentation

Nov 23, 20180 likes188 views

Matteo Berlucchi

An introduction to Pre-Primary Care, a new untapped market in healthcare and how Your.MD is enabling it.

1
Your.MD
Pre-Primary Care: a new health market
1
#health4all @yourdotmd

3
Medical Professionals
are the only source of
trusted information

5
Half the world's population don't
have direct access to healthcare
While in the developing world…

Your.MD - Frontiers Health 2018 Presentation

“The digital health technologies
assisting people with self-care”
Pre-Primary Care: a definition

“Pre-primary care is the most important piece of
primary care as it is what happens before the patient
ever goes to see a doctor and, in many cases, prevents
them from having to actually see a doctor.”
Molly Coye M.D. former Chief Innovation Officer of UCLA Health and Social Entrepreneur in
Residence at the Network for Excellence in Health Innovation
The role of Pre-Primary Care

The case for Pre-Primary Care: strain on Primary Care
GP consultations in 2015 was 370m, up from 220m in 1995 (ONS)
Number of people attending AE in 2016 is 23.6m up from 21.7m
in 2012/13 (ONS)
There are 33,163 GPs in England in June 2018 down from 41,985 GPs
in England in 2016 (ONS)
GPs see the average person 6 times year up from 3 times a year
10 years ago (HSCIC – Trends in consultation rates in GPs)

75% of visits to GPs are for back pain, dermatitis; heartburn, nasal
congestion, constipation, migraine, cough, acne, sprains and headache
(Self Care: N. Pillay, The Economic Burden of Minor Ailments on the NHS, 2010)
The case for Pre-Primary Care: unlocking self-care
47% of millennials and 41% of Gen Xers make every effort to
avoid visiting the doctor (IRI Worldwide, Taking Charge, November 2018)
32% of the population admit to going to the doctor with a condition
like a cold which they admitted they could treat on their own
(Survey of 2,000 UK adults carried out by 3Gem on behalf of PAGB)

The case for Pre-Primary Care: size of opportunity
Consumers grabbing hold of their health and wellness drives a $450-Billion
opportunity (IRI Worldwide, Taking Charge, November 2018)
Self-care conditions are responsible for 19% of AE attendances
in 2014 with a cost of £290m
(IMS/PAGB 2015 – Presentation of self treatable conditions in A&E units in England)
PAGB estimate self treatable conditions account for 57m GP visits and
3.7m AE visits which amount to potential savings of £2.3bn per year
The average person completing an expert patient programme
saves the NHS £1,800 (Expert Patient Programme)

Dr Google didn’t go to Med School
Dr Google gives
the most general
results, not the
most personal

13
Your.MD
AI Personal Health Assistant
to give everyone in the world
We have created the world's first
the best health information
for free, forever

AI can understand the individual situation of each user
and provide the most relevant advice on what to do
Why AI?
Every person is different

15
‘Chat as an interface’
We let users express themselves
in their natural language
Natural Language Processing
for maximum flexibility

16
The best and safest next steps
Your.MD provides the best next steps
including when to see a doctor
What should I do?
We follow the NHS
clinical safety guidelines

Safe and accessible information
Provided by the NHS: everything is written by
Health information must be safe
journalists and verified by doctors

18
OneStop Health™
Finding the best self-care solution
Because a trusted "health marketplace"
has not been created (yet)
Bringing together the best
services to help you

19
OneStop Health™: the best vetted partners
Online and offline
products & services
Doctors, Nurses,
Carers, Therapists
Pharmacies &
Medicines
Tests, Condition
Management

20
Redesigning the patient’s journey
Pre-Primary Care
Primary Care
100%
80%
20%

Download the report
http://www.your.md/report
Join the Pre-Primary Care revolution
http://get.your.md
#health4all
Matteo Berlucchi
matteo@your.md

The document discusses the history and opportunities of mobile health (mHealth). It notes that the author's first memory was of telecoms in healthcare. mHealth leverages mobile technology for health purposes, with over 6 billion mobile subscriptions globally. The convergence of mobile and healthcare is now redesigning the industry for the digital age. Services like 3G Doctor provide documented video consultations with registered doctors over mobile.

Conferências saúdecuf david doherty3GDR

��

The document discusses the rise of mobile technology and its impact on healthcare. It notes that the author's first memory in life was the sound of telecoms in healthcare. Mobile phones are now ubiquitous, with over 6 billion subscriptions globally. The convergence of mobile and healthcare is redesigning the industry, enabling remote access to documented video consultations with doctors through services like 3G Doctor. Undocumented care fails to engage patients, while mobile health solutions allow greater access to documented care through telemedicine.

Social Technologies for eHealthUniversity of Michigan Taubman Health Sciences Library

��

This document discusses the use of social technologies (Web 2.0) in healthcare contexts. It outlines how consumers, clinicians, students, and others use tools like wikis, blogs, social networks and video sharing to collaborate on health issues. Examples are given of support communities and knowledge sharing between patients and providers. While social tools provide benefits of access and support, risks around privacy, security and misinformation must be managed. When used responsibly, these technologies can help empower patients and connect healthcare stakeholders.

Mobile momentumhttp://www.universidadazteca.net/study_offers

��

Future healthcare delivery will need to incorporate mHealth solutions due to changing demographic and economic factors. As populations age and healthcare costs rise, a shift towards preventative care and individual responsibility over one's health is needed. Mobile technologies can help enable this shift by providing remote patient monitoring, data collection for advanced diagnosis, and on-demand access to health information and services. Widespread adoption of mHealth still faces challenges around regulatory approval and data security that will require cooperation across the healthcare industry.

Martin GosslingLucia Garcia

��

This document discusses how remote monitoring of patient recovery after orthopedic procedures using motion sensors can improve outcomes and reduce costs. It outlines how BPMpathway was developed to remotely and cost-effectively monitor joint range of motion and pain levels during recovery. Regular monitoring allows early detection of potential issues and personalized care. The system has shown promising results in trials, reducing length of stays, follow up appointments, and "bounce back" rates. If widely adopted, it could save the UK NHS £100-200 million per year in reduced costs while improving patient motivation and recovery.

International digital health and care congress 2014 - Breakouts: Friday, Sess...The King's Fund

��

Breakout sessions on Friday included various presentations on using digital tools to aid prevention, rehabilitation, and decision making for medical professionals. Specific topics included a stroke association self-help tool, improving an online diabetes risk score, apps to support nursing homes and end-of-life care, image sharing apps for clinicians, touch surgery simulation, cognitive support technology for aging, and using apps and mobile devices to direct specialist care and support behavior change for long-term conditions.

International digital health and care congress 2014 - Breakouts: Friday, Sess...The King's Fund

��

Breakout sessions on Friday included several presentations on using digital tools: 1) To aid prevention and rehabilitation of strokes, diabetes management, and neonatal resuscitation skills. 2) To support both patients and staff through serious gaming, computational creativity, and internet-delivered end-of-life services. 3) To share digital information between clinicians using apps to assess burns, transfer clinical images, and support surgical training decisions. 4) To promote active aging and independence in older adults through cognitive support technology, mobile healthcare assessments, and telecare collaboration.

World's nurse day 2021 MayJustinBenny5

��

The document discusses several topics related to the future of healthcare, including: 1) How technology will continue to transform healthcare over the next decade through advances like artificial intelligence, digital technologies, and remote patient monitoring. 2) Key trends in the next 10 years including more patients, more technology, more information, and a shift to the patient as the ultimate consumer. 3) The roles of different healthcare professionals may change as technology advances, but nurses will still be needed to integrate data and apply their experience and skills. 4) Policies around healthcare access and coverage will also impact the future system, and replacement plans need to consider coverage for vulnerable groups.

Carilion grand rounds 9 30-2011kshup

��

Primary Care Research - A Survey of Healthcare ProfessionalsCogora

��

We polled 1,122 primary healthcare professionals on their views on the state of the NHS, as well as their own morale. The findings included a low level of support for the reform programme, with 64% of respondents believing that it was a step towards privatisation of healthcare. There also appeared to be a call for greater respect of NHS resources. 63% of those polled said that patients should pay for Accident and Emergency visits that were the result of alcohol while 83% said patients should be forced to pay a fee for not attending appointments. The robust sample size and geographically representative sample provides a good insight into the attitudinal trends of a varying range of healthcare professionals. Furthermore, the report includes commentary from leading healthcare professionals, political figures, NHS England as well members of representative bodies such as the Royal College of General Practitioners to further shed insight on the statistical findings.

Case foruhc 1.sflb.ashxmelvin johnson

��

This document makes the case for universal healthcare in the United States. It begins by defining universal healthcare and noting that no American should lack access to care due to inability to pay. It then reviews the moral, economic and cultural arguments for universal coverage. The moral argument is that denying care due to cost is wrong. The economic argument is that universal coverage could save money by reducing uncompensated care and increasing productivity. The cultural argument is that universal coverage aligns with American values like equality and pursuing happiness. The document advocates for universal coverage options that control costs.

Healing community pp, 3.1.13Paulette C. Compton, RN, MSN, MC

��

The Tri-Council for Nursing is a collaborative composed of four national nursing organizations: the American Association of Colleges of Nursing (AACN), the American Nurses Association (ANA), the American Organization of Nurse Executives (AONE), and the National League for Nursing (NLN). These organizations work together to address issues of mutual importance to nursing practice, education, research, and administration.

Cure care and research in English dementia policyshibley

��

The MindEd TrustHealthyBrum

��

eHealth 2014_Radu DopAgora Group

��

This document discusses lessons that can be learned from international healthcare systems to develop a sustainable healthcare system. It provides 3 key lessons: 1. Prioritize health in policymaking by demonstrating how health impacts productivity, education, employment and economic growth. 2. Increase investment in healthcare through dedicated funding and by legislating specific access entitlements. 3. Engage patients by making services patient-centered, ensuring quality communication of information, and driving continuous quality improvement.

PKB 10 yearsGurpreet Sarai MCIPR

��

This document celebrates the 10 year anniversary of Patients Know Best (PKB), which provides a digital platform allowing patients to access and control their own health records. Over the past 10 years, PKB has grown from a small startup to integrating records from hospitals, GP practices, and other services across different regions in the UK and other countries. The document highlights some of the challenges PKB has faced in establishing this new model of empowering patients, and how early champion clinicians helped drive adoption. It also discusses how PKB's vision of integrating fragmented health systems around the patient has driven its success in establishing a sustainable business model.

The e-patient: empowered or overwhelmed? Patient's perspective on new technol...jangeissler

��

System Issues in Public HealthProfessor Jim McManus AFBPsS,FFPH,CSci, FRSB, CPsychol

��

Michael scanlon march 2011 national healthcare conference slidesInvestnet

��

Clinical Information Systems in Global Health CareFelix Chisoni

��

PROJECT REPORTNihad Abdul Nazir

��

The document discusses the healthcare industry and provides context for analyzing delays in patient discharge processes at a hospital from May to July 2015. It describes the objectives of studying delays, the sample size, tools used, and limitations. It then provides an overview of the global healthcare industry, key segments including hospitals, providers and professionals, models for healthcare delivery, and the market size of the industry in different regions. Porter's five forces model is applied to analyze competition in the healthcare industry.

Global_Health_and_Intersectoral_CollaborationSaket Choudhary

��

This document discusses global health and intersectoral collaboration. It begins by defining global health as health problems that transcend national boundaries and are best addressed through international cooperation. It then discusses John Rawls' theory of justice and how global health relates to equality for all. Several definitions of global health from the WHO and Institute of Medicine are provided. The document also discusses the importance of intersectoral collaboration, using the example of different agencies involved in planning the London 2012 Olympics. It outlines challenges and opportunities in global health, such as the need for sustainable development and ensuring environmental considerations.

Ian Sutcliffe Realia Marketing

��

Stfm new orleans april 2011 Paul Grundy

��

The document discusses the growing interest in coordinated and integrated healthcare delivery through models like patient-centered medical homes (PCMHs) and accountable care organizations (ACOs). It notes the potential benefits of these models, including improved quality of care and reduced costs. Specifically, it cites evidence that Geisinger Health System achieved a 9% reduction in total healthcare costs and lower hospital admission and readmission rates through implementing a PCMH-based accountable care model. The long-term goal is for PCMHs and ACOs to transform healthcare delivery in the US to a more coordinated, high-value system focused on primary care.

Surfactants Suppliers India | Surfactants Suppliers DelhiBansal Trading

��

SMART Practices for Responding to FDA Observational Warnings Using Generative AIhrutikapanakrtg

��

Pharma Now Unveils Groundbreaking Industry Insights in Latest Issue Pharma Now is thrilled to introduce its latest feature, Navigating the Digital Frontier, a comprehensive deep dive into the latest advancements, challenges, and opportunities shaping the pharmaceutical industry. This edition provides invaluable insights for professionals in pharmaceuticals, biotechnology, and regulatory compliance, equipping them with the knowledge to navigate the ever-evolving landscape. Inside This Edition: Global Industry Trends & Insights: Explore the most significant technological innovations, regulatory changes, and market disruptions that are shaping the future of pharmaceuticals. Gain insights from industry experts on how companies can adapt and stay ahead in a competitive market. Global Events & Conferences: A carefully curated list of the most influential upcoming pharmaceutical events, conferences, and summits worldwide, designed to foster collaboration and industry networking. Stay informed about where to find the best opportunities for learning and partnership-building. Market Insights & Trends: Get an in-depth look at key market dynamics, investment trends, and strategic shifts in the pharmaceutical industry. Understand how companies are responding to emerging challenges and leveraging new opportunities to drive growth. Exclusive Leadership Interview: "In Talks With Leadership" A special feature with Dr. Ashok Kumar Bhattacharya, a distinguished industry leader, who shares his expert perspectives on the latest advancements and the future of pharmaceuticals. Gain firsthand insights into the strategic decisions shaping the industry today. Leveraging Generative AI for Regulatory Compliance Discover how pharmaceutical companies can integrate generative AI technologies to enhance regulatory compliance, respond efficiently to FDA warnings, and streamline operational efficiency. This feature provides an in-depth analysis of AI-driven solutions transforming the industry. With the pharmaceutical sector constantly evolving, Navigating the Digital Frontier serves as an essential resource for industry leaders, professionals, and innovators looking to stay ahead in the digital age. Stay informed and explore the future of pharmaceuticals with Pharma Now. For further details, partnership inquiries, or to access the latest issue, visit

YEASTS AND DIMORPHIC FUNGI powerpoint pptdrsabashama21

��

VSWarehouse 3: Enterprise-Grade Genomic Analysis Across Cloud and On-Premise ...Golden Helix

��

Clinical laboratories and genomic research centers are increasingly seeking flexible deployment options that can seamlessly span both on-premises and cloud environments while maintaining enterprise-grade security and control. VSWarehouse 3's enterprise platform capabilities enable organizations to leverage their existing infrastructure while scaling into the cloud on their own terms. Join us to discover how VSWarehouse 3's cross-platform deployment model combines the security of on-premises installations with the scalability of cloud computing, all accessible through a streamlined browser interface. In this webcast, we will: Demonstrate how VSWarehouse 3 enables deployments across on-premises servers and major cloud providers (AWS/Azure) through our Bring Your Own Cloud (BYOC) model. Explore enterprise-grade security features including role-based access controls, Active Directory integration, and workspace isolation that enable secure multi-team collaboration. Show how organizations can replace legacy remote access solutions with VSWarehouse 3's native browser-based platform, simplifying deployment while enhancing scalability. Detail our comprehensive workflow automation capabilities, including integration with upstream providers and support for custom analysis pipelines. This session will provide IT leaders and laboratory directors with practical insights into how VSWarehouse 3's enterprise platform can modernize their genomic analysis infrastructure while maintaining complete control over their data, security, and resource allocation. Whether you're looking to extend existing on-premises capabilities or implement a full cloud deployment, learn how VSWarehouse 3 can support your organization's growth and evolution.

lecturenote_1989262961Chapter 4- Microwave Solid State Devices.pdfalyaamohammed251

��

Transform Hospital Security 7 Reasons to Use Visitor Management Software.pdfHealthray Technologies Pvt. Ltd.

��

🔐 Transform Hospital Security: 7 Reasons to Use Visitor Management Software! 🏥 Hospitals handle a high volume of visitors daily, making security and patient safety a top priority. A smart Visitor Management System ensures controlled access, real-time tracking, and seamless check-ins while reducing unauthorized entries. 🚦💡 ✅ Instant Visitor Authentication ✅ Faster, Paperless Check-Ins ✅ Enhanced Security & Compliance ✅ Contactless & Hygienic Entry ✅ Automated Alerts for Unauthorized Access ✅ Seamless Integration with Hospital Systems ✅ Better Patient & Staff Protection 🏥 Upgrade to a smarter, safer hospital today! 💡🔐

More Related Content

Similar to Your.MD - Frontiers Health 2018 Presentation (16)

Carilion grand rounds 9 30-2011kshup

��

Primary Care Research - A Survey of Healthcare ProfessionalsCogora

��

Case foruhc 1.sflb.ashxmelvin johnson

��

Healing community pp, 3.1.13Paulette C. Compton, RN, MSN, MC

��

Cure care and research in English dementia policyshibley

��

The MindEd TrustHealthyBrum

��

eHealth 2014_Radu DopAgora Group

��

PKB 10 yearsGurpreet Sarai MCIPR

��

The e-patient: empowered or overwhelmed? Patient's perspective on new technol...jangeissler

��

System Issues in Public HealthProfessor Jim McManus AFBPsS,FFPH,CSci, FRSB, CPsychol

��

Michael scanlon march 2011 national healthcare conference slidesInvestnet

��

Clinical Information Systems in Global Health CareFelix Chisoni

��

PROJECT REPORTNihad Abdul Nazir

��

Global_Health_and_Intersectoral_CollaborationSaket Choudhary

��

Ian Sutcliffe Realia Marketing

��

Stfm new orleans april 2011 Paul Grundy

��

Carilion grand rounds 9 30-2011kshup

��

Primary Care Research - A Survey of Healthcare ProfessionalsCogora

��

Case foruhc 1.sflb.ashxmelvin johnson

��

Healing community pp, 3.1.13Paulette C. Compton, RN, MSN, MC

��

Cure care and research in English dementia policyshibley

��

The MindEd TrustHealthyBrum

��

eHealth 2014_Radu DopAgora Group

��

PKB 10 yearsGurpreet Sarai MCIPR

��

The e-patient: empowered or overwhelmed? Patient's perspective on new technol...jangeissler

��

System Issues in Public HealthProfessor Jim McManus AFBPsS,FFPH,CSci, FRSB, CPsychol

��

Michael scanlon march 2011 national healthcare conference slidesInvestnet

��

Clinical Information Systems in Global Health CareFelix Chisoni

��

PROJECT REPORTNihad Abdul Nazir

��

Global_Health_and_Intersectoral_CollaborationSaket Choudhary

��

Ian Sutcliffe Realia Marketing

��

Stfm new orleans april 2011 Paul Grundy

��

Recently uploaded (20)

Surfactants Suppliers India | Surfactants Suppliers DelhiBansal Trading

��

SMART Practices for Responding to FDA Observational Warnings Using Generative AIhrutikapanakrtg

��

YEASTS AND DIMORPHIC FUNGI powerpoint pptdrsabashama21

��

VSWarehouse 3: Enterprise-Grade Genomic Analysis Across Cloud and On-Premise ...Golden Helix

��

lecturenote_1989262961Chapter 4- Microwave Solid State Devices.pdfalyaamohammed251

��

Transform Hospital Security 7 Reasons to Use Visitor Management Software.pdfHealthray Technologies Pvt. Ltd.

��

MALARIA - Pharm D III year Therap .pptxAyesha Fatima

��

Malaria is a life-threatening disease. Its typically transmitted through the bite of an infected Anopheles mosquito. Infected mosquitoes carry the Plasmodium parasite. When this mosquito bites you, the parasite is released into your blood stream. Phylum : Protozoa Subphylum : Apicomplexa (Sporozoa) Class : Telosporea Genus : Plasmodium Species : vivax Plasmodium is one of the most harmful parasites of man. It is a digenetic, intracellular parasite that lives in the liver cells and RBC of man. (It is extracellular in mosquito). Its primary host is the female Anopheles mosquito and the secondary host is man. Reservoir host is monkey. The infective stage is sickle shaped sporozoite and the mode of infection is inoculation. Four species of Plasmodium cause four types of malaria in man. They are i) Plasmodium vivax – benign tertian malaria ii) Plasmodium falciparum – malignant tertian malaria iii) Plasmodium ovale – mild tertian malaria iv) Plasmodium malariae – quartan malaria Of all these four species, Plasmodium vivax is the most common and most widely distributed malaria parasite. OBJECTIVES AND USE OF ANTIMALARIAL DRUGS The aims of using drugs in relation to malarial infection are: (i) To prevent clinical attack of malaria (prophylactic). (ii) To treat clinical attack of malaria (clinical curative). (iii) To completely eradicate the parasite from the patient’s body (radical curative). (iv) To cutdown human-to-mosquito transmission (gametocidal). These are achieved by attacking the parasite at its various stages of life cycle in the human host . Antimalarials that act on erythrocytic schizogony are called erythrocytic schizontocides Antimalarials that act on pre erythrocytic as well as exoerythrocytic (P. vivax) stages in liver are called tissue schizontocides, Antimalarials which kill gametocytes in blood are called gametocides. Severe and complicated falciparum malaria This includes P. falciparum infection attended by any one or more of— Hyperparasitaemia, Hyperpyrexia, Fluid and electrolyte imbalance, Acidosis, Hypoglycaemia, Prostration, Cardiovascular collapse, Jaundice, Severe anaemia, Spontaneous bleeding, Pulmonary edema, Haemoglobinuria, Black water fever, Renal failure Cerebral malaria. Artesunate: 2.4 mg/kg i.v. or i.m., followed by 2.4 mg/kg after 12 and 24 hours, and then once daily for 7 days. Switchover to 3 day oral ACT in between whenever the patient can take and tolerate oral medication. or Artemether: 3.2 mg/kg i.m. on the 1st day, followed by 1.6 mg/kg daily for 7 days. Switchover to 3 day oral ACT in between whenever the patient is able to take oral medication. or Arteether: 3.2 mg/kg i.m. on the 1st day, followed by 1.6 mg/kg daily for the next 4 days. Switchover to 3 day oral ACT inbetween whenever the patient is able to take oral medication. or Quinine diHCI: 20 mg/kg (loading dose) diluted in 10 ml/kg 5% dextrose/dextrose-saline and infused i.v. over 4 hours, followed by 10 mg/kg.

PRARTHANA AND ARPITA (euthanasia) 1.pptxrydhemsadscreation18

��

This PowerPoint presentation explores the complex and emotional topic of euthanasia, focusing on its legal, ethical, and social dimensions. It covers the current legal status of euthanasia in India, including the landmark Aruna Shanbaug case, and examines global perspectives from countries like the Netherlands, Belgium, and Canada. The presentation also delves into the arguments for and against euthanasia, highlighting the ethical challenges, healthcare burden, and public opinion in India. With data-driven insights, real-life examples, and engaging visuals, this presentation aims to spark a thoughtful discussion on whether euthanasia should be legalized in India and how it can be implemented responsibly.

Diabetic neuropathy taking evidence to clinicAkshajGupta5

��

Cases epilepsy intresting by praveen gupta.pptAkshajGupta5

��

Importance of Dental Hygiene OAVS Science Seminaradarwindisciple

��

Blindness and Vision Impairment; NPCBVI.pptxPuja Kumari

��

15 Tips for Healthcare Institutions to Streamline Operations.pdfCRMJetty

��

Brain stroke: Symptoms, Classification, prevention and management .pptxJoginder Singh

��

Health Care System in Japan (Country).pptxPuja Kumari

��

HAIR CYCLE and HAIR GROWTH _PDF..........saisumanthchinnari5

��

Quality Control in Pharmaceutical Manufacturing.pdfhrutikapanakrtg

��

Quality control is the cornerstone of pharmaceutical manufacturing, ensuring patient safety, product efficacy, and industry integrity. In an environment where precision and reliability are paramount, the rigorous standards and protocols of quality control play a pivotal role at every stage of the manufacturing process. This discussion delves into the significance of quality control in pharmaceutical manufacturing and its far-reaching implications for healthcare and society. We also address potential challenges in quality control and offer a sneak peek into the future. Without further ado, let’s get reading! Safeguarding Patient Safety The foremost priority of quality control in pharmaceutical manufacturing is to safeguard patient safety. Quality control ensures that pharmaceutical products meet stringent purity, potency, and efficacy standards through meticulous testing, analysis, and inspection. Quality control minimises the likelihood of adverse reactions and ensures patients receive safe and effective medications by detecting and mitigating potential risks, such as contamination or impurities. Ensuring Product Efficacy In addition to safety, quality control is crucial in ensuring product efficacy. Pharmaceutical products must deliver the intended therapeutic benefits consistently and reliably. Quality control measures, including assay testing, dissolution profiling, and stability studies, validate the potency and performance of pharmaceutical formulations. By maintaining consistency in product quality, quality control instils confidence in healthcare professionals and patients, ensuring that they can rely on pharmaceutical products to deliver the desired clinical outcomes. Compliance with Regulatory Standards The pharmaceutical industry operates within a highly regulated framework governed by stringent quality standards and regulatory requirements. Quality control is essential for compliance with regulatory agencies such as the Food and Drug Administration and the European Medicines Agency. By adhering to Good Manufacturing Practices (GMP) and other regulatory guidelines, pharmaceutical manufacturers demonstrate their commitment to producing safe, reliable, high-quality products that meet regulatory standards. Preventing Product Recalls and Litigation Product recalls due to quality issues can have significant financial and reputational repercussions for pharmaceutical companies. Quality control is a proactive measure to prevent product recalls by identifying and addressing potential quality deviations early in manufacturing. By implementing robust quality control protocols, manufacturers reduce the risk of costly recalls, litigation, and damage to their brand reputation, safeguarding their long-term viability and success.

formulation & evaluation of ginseng syrup by CLASSIC PPT.pptxboringgroup10

��

A Roadmap for Strengthening Health Leadership in the Western Pacific RegionBecky Goins

��

Strong leadership and a highly skilled health workforce are essential for achieving universal health coverage and building resilient health systems. This strategic storyboard presents a comprehensive approach to leadership development and capacity building for mid-level health professionals in the Western Pacific Region specifically, but could be applied to other geographic regions. This deck compiles global best practices, successful case studies from various countries, and evidence-based recommendations in a digestible storyboard to build sustainable health leadership programs. 📖 Who Should Read This? - Public health leaders, policymakers, and capacity-building professionals - Global health consultants and leadership trainers - Organizations looking to strengthen workforce development in health systems

HPV and Cervical Cancer Prevention, Symptoms and Early Detection (1).pdfCradleChildrenHospit

��

Surfactants Suppliers India | Surfactants Suppliers DelhiBansal Trading

��

SMART Practices for Responding to FDA Observational Warnings Using Generative AIhrutikapanakrtg

��

YEASTS AND DIMORPHIC FUNGI powerpoint pptdrsabashama21

��

VSWarehouse 3: Enterprise-Grade Genomic Analysis Across Cloud and On-Premise ...Golden Helix

��

lecturenote_1989262961Chapter 4- Microwave Solid State Devices.pdfalyaamohammed251

��

Transform Hospital Security 7 Reasons to Use Visitor Management Software.pdfHealthray Technologies Pvt. Ltd.

��

MALARIA - Pharm D III year Therap .pptxAyesha Fatima

��

PRARTHANA AND ARPITA (euthanasia) 1.pptxrydhemsadscreation18

��

Diabetic neuropathy taking evidence to clinicAkshajGupta5

��

Cases epilepsy intresting by praveen gupta.pptAkshajGupta5

��

Importance of Dental Hygiene OAVS Science Seminaradarwindisciple

��

Blindness and Vision Impairment; NPCBVI.pptxPuja Kumari

��

15 Tips for Healthcare Institutions to Streamline Operations.pdfCRMJetty

��

Brain stroke: Symptoms, Classification, prevention and management .pptxJoginder Singh

��

Health Care System in Japan (Country).pptxPuja Kumari

��

HAIR CYCLE and HAIR GROWTH _PDF..........saisumanthchinnari5

��

Quality Control in Pharmaceutical Manufacturing.pdfhrutikapanakrtg

��

formulation & evaluation of ginseng syrup by CLASSIC PPT.pptxboringgroup10

��

A Roadmap for Strengthening Health Leadership in the Western Pacific RegionBecky Goins

��

HPV and Cervical Cancer Prevention, Symptoms and Early Detection (1).pdfCradleChildrenHospit

��

Your.MD - Frontiers Health 2018 Presentation

1. 1 Your.MD Pre-Primary Care: a new health market 1 #health4all @yourdotmd

2. Our body is a 'black box'

3. 3 Medical Professionals are the only source of trusted information

4. This is the result

5. 5 Half the world's population don't have direct access to healthcare While in the developing world…

7. “The digital health technologies assisting people with self-care” Pre-Primary Care: a definition

8. “Pre-primary care is the most important piece of primary care as it is what happens before the patient ever goes to see a doctor and, in many cases, prevents them from having to actually see a doctor.” Molly Coye M.D. former Chief Innovation Officer of UCLA Health and Social Entrepreneur in Residence at the Network for Excellence in Health Innovation The role of Pre-Primary Care

9. The case for Pre-Primary Care: strain on Primary Care GP consultations in 2015 was 370m, up from 220m in 1995 (ONS) Number of people attending AE in 2016 is 23.6m up from 21.7m in 2012/13 (ONS) There are 33,163 GPs in England in June 2018 down from 41,985 GPs in England in 2016 (ONS) GPs see the average person 6 times year up from 3 times a year 10 years ago (HSCIC – Trends in consultation rates in GPs)

10. 75% of visits to GPs are for back pain, dermatitis; heartburn, nasal congestion, constipation, migraine, cough, acne, sprains and headache (Self Care: N. Pillay, The Economic Burden of Minor Ailments on the NHS, 2010) The case for Pre-Primary Care: unlocking self-care 47% of millennials and 41% of Gen Xers make every effort to avoid visiting the doctor (IRI Worldwide, Taking Charge, November 2018) 32% of the population admit to going to the doctor with a condition like a cold which they admitted they could treat on their own (Survey of 2,000 UK adults carried out by 3Gem on behalf of PAGB)

11. The case for Pre-Primary Care: size of opportunity Consumers grabbing hold of their health and wellness drives a $450-Billion opportunity (IRI Worldwide, Taking Charge, November 2018) Self-care conditions are responsible for 19% of AE attendances in 2014 with a cost of £290m (IMS/PAGB 2015 – Presentation of self treatable conditions in A&E units in England) PAGB estimate self treatable conditions account for 57m GP visits and 3.7m AE visits which amount to potential savings of £2.3bn per year The average person completing an expert patient programme saves the NHS £1,800 (Expert Patient Programme)

12. Dr Google didn’t go to Med School Dr Google gives the most general results, not the most personal

13. 13 Your.MD AI Personal Health Assistant to give everyone in the world We have created the world's first the best health information for free, forever

14. AI can understand the individual situation of each user and provide the most relevant advice on what to do Why AI? Every person is different

15. 15 ‘Chat as an interface’ We let users express themselves in their natural language Natural Language Processing for maximum flexibility

16. 16 The best and safest next steps Your.MD provides the best next steps including when to see a doctor What should I do? We follow the NHS clinical safety guidelines

17. Safe and accessible information Provided by the NHS: everything is written by Health information must be safe journalists and verified by doctors

18. 18 OneStop Health™ Finding the best self-care solution Because a trusted "health marketplace" has not been created (yet) Bringing together the best services to help you

19. 19 OneStop Health™: the best vetted partners Online and offline products & services Doctors, Nurses, Carers, Therapists Pharmacies & Medicines Tests, Condition Management

20. 20 Redesigning the patient’s journey Pre-Primary Care Primary Care 100% 80% 20%

21. Download the report http://www.your.md/report Join the Pre-Primary Care revolution http://get.your.md #health4all Matteo Berlucchi matteo@your.md

�ݺ�ߣ

Your.MD - Frontiers Health 2018 Presentation

Recommended

More Related Content

Similar to Your.MD - Frontiers Health 2018 Presentation (16)

Recently uploaded (20)

Your.MD - Frontiers Health 2018 Presentation